14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KTRA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Kintara Therapeutics Inc. stock price ended at $0.151 on Friday, after losing 3.75%.
(Updated on May 03, 2024)

Buy or Hold candidate since Apr 19, 2024 Gain 24.63% PDF

The Kintara Therapeutics Inc. stock price fell by -3.75% on the last day (Friday, 3rd May 2024) from $0.157 to $0.151. During the last trading day the stock fluctuated 8.34% from a day low at $0.150 to a day high of $0.162. The price has been going up and down for this period, and there has been a 24.63% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -644 thousand shares and in total, 3 million shares were bought and sold for approximately $420.24 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 28.15% during the next 3 months and, with a 90% probability hold a price between $0.137 and $0.228 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KTRA Signals & Forecast

The Kintara Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.154. On a fall, the stock will find some support from the long-term average at approximately $0.120. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 29, 2024, and so far it has fallen -6.95%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Kintara Therapeutics Inc. stock

Kintara Therapeutics Inc. finds support from accumulated volume at $0.149 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0125 between high and low, or 8.34%. For the last week the stock has had daily average volatility of 11.27%.

Our recommended stop-loss: $0.143 (-5.68%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (KTRA) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Kintara Therapeutics Inc. to open at $0.155, and during the day (based on 14 day Average True Range), to move between $0.132 and $0.171, which gives a possible trading interval of +/-$0.0197 (+/-13.02%) up or down from last closing price. If Kintara Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 26.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.149 (1.65%) than the resistance at $0.158 (4.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Kintara Therapeutics Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.250. We will update the financials statements for Kintara Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.81% in the first trading day after earnings release.

Is Kintara Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Kintara Therapeutics Inc. stock to perform well in the short-term.

Current score: 1.501 Buy Candidate Unchanged

Predicted Opening Price for Kintara Therapeutics Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$0.155 ( 2.14%) $0.151

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KTRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.167 10.40 %
R2 0.162 7.24 %
R1 0.159 5.29 %
Current price: 0.151
Support S1 0.150 -1.02 %
S2 0.147 -2.97 %
S3 0.142 -6.12 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.164 8.39 %
R2 0.163 7.47 %
R1 0.158 4.43 %
Current price 0.151
Support S1 0.149 -1.65%
S2 0.144 -5.02%
S3 0.122 -19.30%

FAQ

What is the symbol for Kintara Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Kintara Therapeutics Inc. is KTRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Kintara Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Kintara Therapeutics Inc. stock to perform well in the short-term.

How to buy Kintara Therapeutics Inc. Stock?
Kintara Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Kintara Therapeutics Inc. Stock.

What's the current price of Kintara Therapeutics Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Kintara Therapeutics Inc. (KTRA) share was $0.151.

What is the 52-week high and low for Kintara Therapeutics Inc. Stock?
The 52-week high for Kintara Therapeutics Inc. Stock is $5.60 and the 52-week low is $0.0810.

What is the market capitalization of Kintara Therapeutics Inc. Stock?
As of the May 03, 2024, the market capitalization of Kintara Therapeutics Inc. is 8.368M.

When is the next earnings date for Kintara Therapeutics Inc.?
The upcoming earnings date for Kintara Therapeutics Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Kintara Therapeutics Inc.

Kintara Therapeutics. Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri... KTRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT